National Bank of Canada’s Edesa Biotech EDSA Stock Holding History

National Bank of Canada’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8	Closed	-$36	–	3008
2024 Q3	$36	Hold	8	–	–	﹤0.01%	2608
2024 Q2	$33	Hold	8	–	–	﹤0.01%	2662
2024 Q1	$36	Hold	8	–	–	﹤0.01%	2690
2023 Q4	$37	Sell	8 -1	-11%	-$4	﹤0.01%	2673
2023 Q3	$40	Buy	9 +1	+13%	+$6	﹤0.01%	2736
2023 Q2	$45	Hold	8	–	–	﹤0.01%	2695
2023 Q1	$51	Sell	8 -1,135	-99%	-$11.8K	﹤0.01%	2665
2022 Q4	$17.2K	Buy	1,143 +572	+100%	+$4.26K	﹤0.01%	2045
2022 Q3	$4K	Hold	571	–	–	﹤0.01%	2379
2022 Q2	$6K	Sell	571 -858	-60%	-$12.6K	﹤0.01%	2378
2022 Q1	$30K	Buy	1,429 +1,341	+1,524%	+$37.1K	﹤0.01%	2030
2021 Q4	$3K	Buy	+88	New	+$4.21K	﹤0.01%	2611

Other funds holding EDSA

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada's EDSA Position: Q4 2024 in Review

National Bank of Canada sold out of Edesa Biotech (EDSA) in Q4 2024, closing a stake of 8 shares — an estimated $36 sold.

National Bank of Canada first reported a position in EDSA in Q4 2021 and held it in 12 quarters. The position peaked at $30K in Q1 2022. 17 funds tracked by Wall St. Rank hold EDSA as of Q4 2024.

National Bank of Canada reported no remaining Edesa Biotech position as of Q4 2024 after selling out during the quarter.
National Bank of Canada sold 8 Edesa Biotech shares in Q4 2024, an estimated $36.
National Bank of Canada first reported a position in Edesa Biotech in Q4 2021 and held it in 12 quarters.
National Bank of Canada's Edesa Biotech position peaked at $30K in Q1 2022.
17 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2024.

Based on National Bank of Canada's 13F filing for Q4 2024, filed 12 Feb 2025.